Yuqi Wu

机构：University of Alberta, Sun Yat-sen University, Beijing University of Chinese Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Sichuan University, Southwest Medical University, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine · ORCID：0000-0002-4513-813X

发表论文 61 篇 · 总被引 530 次 · h-index 12

代表论文

• Managing strategies of chemotherapy and radiotherapy-induced oral mucositis (2025 · Cancer Treatment Reviews · 被引 19)
• Induction PD-1 inhibitor toripalimab plus chemotherapy followed by concurrent chemoradiotherapy and consolidation toripalimab for bulky locally advanced non-small-cell lung cancer: protocol for a randomized phase II trial (InTRist study) (2024 · Frontiers in Immunology · 被引 17)
• Macrophages in CRSwNP: Do they deserve more attention? (2024 · International Immunopharmacology · 被引 15)
• The preliminary results of a randomized phase II trial evaluating induction toripalimab plus chemotherapy followed by concurrent chemoradiotherapy and consolidation toripalimab in bulky unresectable stage III non-small-cell lung cancer (InTRist). (2025 · Journal of Clinical Oncology · 被引 11)
• Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients (2025 · Signal Transduction and Targeted Therapy · 被引 10)
• Dynamic bTMB combined with residual ctDNA improves survival prediction in locally advanced NSCLC patients with chemoradiotherapy and consolidation immunotherapy (2024 · Journal of the National Cancer Center · 被引 10)